Summary
DeusPower TESTOMED E 250 Lab Test ResultsSummaryThe product TESTOMED E 250, manufactured by DEUS MEDICAL, underwent independent sterility testing to ensure compliance with pharmacopoeia standards. The sample, identified by batch number TU83429 (Manufactured 05/2020), was submitted by DEUSPOWER.SHOP and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The sterility test was conducted according to pharmacopoeia 2.6.1 guidelines, and the result confirmed that the product is sterile.
The testing process began on 11 September 2020, with the sample received on the same date, and analysis completed on 24 October 2020. The accredited analysis confirms the sterility of the product; however, continued monitoring and independent testing remain important to ensure product consistency. This report is provided as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: DEUS MEDICAL
- Product Name: TESTOMED E 250
- Active Ingredient: Testosterone Enanthate
- Batch Number: TU83429
- Manufacturing Date: 05/2020
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #08648
- Testing Ordered: 11 September 2020
- Sample Received: 11 September 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
- Sterility Test Specification: Conducted as per pharmacopoeia 2.6.1
- Sterility Test Result: Sterile
- Additional Notes: Accredited analysis
Verification Details
- Verification URL: https://janoshik.com/tests/08648_PT1JDGNKBHB4
Evaluation of Reseller-Submitted Testing
This analysis confirms the sterility of the tested product; however, as with all reseller-submitted tests, it is essential to consider potential biases. Resellers may submit specific batches for testing that meet high-quality standards, but this does not necessarily reflect the quality consistency across the broader market. Independent third-party testing across multiple batches would further ensure product reliability.
Conclusion
The analysis confirms that TESTOMED E 250 is sterile, meeting pharmacopoeia sterility standards. This indicates that the tested batch adheres to good manufacturing practices. However, continued independent testing of multiple batches is encouraged to verify consistency across production. This report supports educational and harm reduction efforts, helping consumers make informed decisions regarding testosterone enanthate products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
